The therapeutic potential of modulating the ceramide/sphingomyelin pathway
- PMID: 12093880
- PMCID: PMC151041
- DOI: 10.1172/JCI16127
The therapeutic potential of modulating the ceramide/sphingomyelin pathway
Figures



References
-
- Kolesnick RN. Sphingomyelin and derivatives as cellular signals. Prog Lipid Res. 1991;30:1–38. - PubMed
-
- Kolesnick RN. 1,2-Diacylglycerols but not phorbol esters stimulate sphingomyelin hydrolysis in GH3pituitary cells. J Biol Chem. 1987;262:16759–16762. - PubMed
-
- Kolesnick RN, Clegg S. 1,2-Diacylglycerols, but not phorbol esters, activate a potential inhibitory pathway for protein kinase C in GH3pituitary cells: evidence for involvement of a sphingomyelinase. J Biol Chem. 1988;263:6534–6537. - PubMed
-
- Kolesnick RN. Sphingomyelinase action inhibits phorbol ester-induced differentiation of human promyelocytic leukemic (HL-60) cells. J Biol Chem. 1989;264:7617–7623. - PubMed
-
- Okazaki T, Bell RM, Hannun Y. Sphingomyelin turnover induced by vitamin D3in HL-60 cells: role in cell differentiation. J Biol Chem. 1989;264:19076–19080. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources